Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sverre Rørtveit, Dag Harald Skutlaberg, Nina Langeland & Guri Rortveit. (2014) The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway. Scandinavian Journal of Infectious Diseases 46:12, pages 832-837.
Read now
Read now
Martin Sundqvist. (2014) Reversibility of antibiotic resistance. Upsala Journal of Medical Sciences 119:2, pages 142-148.
Read now
Read now
A. Österlund, G. Kahlmeter, S Hæggman, B. Olsson-Liljequist & A SWEDISH STUDY GROUP ON FUSIDIC ACID RESISTANT S AUREUS. (2006) Staphylococcus aureus resistant to fusidic acid among Swedish children: A follow-up study. Scandinavian Journal of Infectious Diseases 38:5, pages 332-334.
Read now
Read now
Michael J Sladden & Graham A Johnston. (2005) Current options for the treatment of impetigo in children. Expert Opinion on Pharmacotherapy 6:13, pages 2245-2256.
Read now
Read now
Articles from other publishers (34)
I. V. Borisov. (2021) Povidone iodine — new possibilities of a familiar dressing (literature review). Wounds and wound infections. The prof. B.M. Kostyuchenok journal 8:3, pages 14-20.
Crossref
Crossref
Bahareh Hajikhani, Mehdi Goudarzi, Sareh Kakavandi, Sana Amini, Samira Zamani, Alex van Belkum, Hossein Goudarzi & Masoud Dadashi. (2021) The global prevalence of fusidic acid resistance in clinical isolates of Staphylococcus aureus: a systematic review and meta-analysis. Antimicrobial Resistance & Infection Control 10:1.
Crossref
Crossref
Ruben Barreto, Brigitte Barrois, Julien Lambert, Surbhi Malhotra-Kumar, Victor Santos-Fernandes & Stan Monstrey. (2020) Addressing the challenges in antisepsis: focus on povidone iodine. International Journal of Antimicrobial Agents 56:3, pages 106064.
Crossref
Crossref
P. Nenoff, D. Koch, C. Krüger, C. Drechsel & P. Mayser. (2017) New insights on the antibacterial efficacy of miconazole in vitro. Mycoses 60:8, pages 552-557.
Crossref
Crossref
Jason Trubiano & M. Lindsay Grayson. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
304
309.e2
.
A. Jogenfors, L. Stark, J. Svefors, S. Löfgren, B.-E. Malmvall & A. Matussek. (2013) A recommendation to perform a blood culture before the administration of intravenous antibiotics increased the detection of Staphylococcus aureus bacteremia. European Journal of Clinical Microbiology & Infectious Diseases 33:5, pages 789-795.
Crossref
Crossref
Jean-Marie Lachapelle, Olivier Castel, Alejandro Fueyo Casado, Bernard Leroy, Giuseppe Micali, Dominique Tennstedt & Julien Lambert. (2013) Antiseptics in the era of bacterial resistance: a focus on povidone iodine. Clinical Practice 10:5, pages 579-592.
Crossref
Crossref
Yingchao Liu, Wenjing Geng, Yonghong Yang, Chuanqing Wang, Yaojie Zheng, Yunxiao Shang, Dejing Wu, Xiangmei Li, Lijuan Wang, Sangjie Yu, Kaihu Yao & Xuzhuang Shen. (2012) Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections. FEMS Immunology & Medical Microbiology 64:2, pages 212-218.
Crossref
Crossref
Maike Koningstein, Leon Groen, Kathelijn Geraats-Peters, Suzanne Lutgens, Ariene Rietveld, Petr Jira, Jan Kluytmans, Sabine C de Greeff, Mirjam Hermans & Peter M Schneeberger. (2012) The use of typing methods and infection prevention measures to control a bullous impetigo outbreak on a neonatal ward. Antimicrobial Resistance and Infection Control 1:1, pages 37.
Crossref
Crossref
Chih-Ming Chen, Mei Huang, Huei-Fen Chen, Se-Chin Ke, Chia-Ru Li, Jen-Hsien Wang & Lii-Tzu Wu. (2011) Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital. BMC Microbiology 11:1.
Crossref
Crossref
M. Dalager-Pedersen, M. Søgaard & H. C. Schønheyder. (2011) Staphylococcus aureus skin and soft tissue infections in primary healthcare in Denmark: a 12-year population-based study. European Journal of Clinical Microbiology & Infectious Diseases 30:8, pages 951-956.
Crossref
Crossref
S. Rortveit, D. H. Skutlaberg, N. Langeland & G. Rortveit. (2011) Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics. Journal of Antimicrobial Chemotherapy 66:6, pages 1360-1364.
Crossref
Crossref
Helena Masiuk, Katarzyna Kopron, Dorothee Grumann, Christiane Goerke, Julia Kolata, Joanna Jursa-Kulesza, Stefania Giedrys-Kalemba, Barbara M. Bröker & Silva Holtfreter. (2010)
Association of Recurrent Furunculosis with Panton-Valentine Leukocidin and the Genetic Background of
Staphylococcus aureus
. Journal of Clinical Microbiology 48:5, pages 1527-1535.
Crossref
Crossref
A. Mitra, M. Mohanraj & M. Shah. (2009)
High levels of fusidic acid-resistant
Staphylococcus aureus
despite restrictions on antibiotic use
. Clinical and Experimental Dermatology 34:2, pages 136-139.
Crossref
Crossref
A. Wimmerstedt & G. Kahlmeter. (2008) Associated antimicrobial resistance in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes. Clinical Microbiology and Infection 14:4, pages 315-321.
Crossref
Crossref
O G Elisyutina & E S Fedenko. (2008) Preparaty fuzidovoy kislotyv n aruzhnoy terapii atopicheskogodermatita. Russian Journal of Allergy 5:1, pages 74-78.
Crossref
Crossref
S. Rørtveit & G. Rortveit. (2007) Impetigo in epidemic and nonepidemic phases: an incidence study over 4½ years in a general population. British Journal of Dermatology 157:1, pages 100-105.
Crossref
Crossref
A. J. O'Neill, A. R. Larsen, R. Skov, A. S. Henriksen & I. Chopra. (2007)
Characterization of the Epidemic European Fusidic Acid-Resistant Impetigo Clone of
Staphylococcus aureus
. Journal of Clinical Microbiology 45:5, pages 1505-1510.
Crossref
Crossref
A. J. O'Neill, F. McLaws, G. Kahlmeter, A. S. Henriksen & I. Chopra. (2007) Genetic Basis of Resistance to Fusidic Acid in Staphylococci. Antimicrobial Agents and Chemotherapy 51:5, pages 1737-1740.
Crossref
Crossref
T. Norén, T. Åkerlund, M. Wullt, L. G. Burman & M. Unemo. (2007)
Mutations in
fusA
Associated with Posttherapy Fusidic Acid Resistance in
Clostridium difficile
. Antimicrobial Agents and Chemotherapy 51:5, pages 1840-1843.
Crossref
Crossref
Martin Sundqvist & Gunnar Kahlmeter. (2007) Effect of excluding duplicate isolates of Escherichia coli and Staphylococcus aureus in a 14 year consecutive database. Journal of Antimicrobial Chemotherapy 59:5, pages 913-918.
Crossref
Crossref
T. Norén, M. Wullt, Thomas Åkerlund, E. Bäck, I. Odenholt & L. G. Burman. (2006)
Frequent Emergence of Resistance in
Clostridium difficile
during Treatment of
C. difficile
-Associated Diarrhea with Fusidic Acid
. Antimicrobial Agents and Chemotherapy 50:9, pages 3028-3032.
Crossref
Crossref
B. P. Howden & M. L. Grayson. (2006) Dumb and Dumber--The Potential Waste of a Useful Antistaphylococcal Agent: Emerging Fusidic Acid Resistance in Staphylococcus aureus. Clinical Infectious Diseases 42:3, pages 394-400.
Crossref
Crossref
Alexander John O'Neill & Ian Chopra. (2006)
Molecular basis of
fusB
-mediated resistance to fusidic acid in
Staphylococcus aureus
. Molecular Microbiology 59:2, pages 664-676.
Crossref
Crossref
Martin J. McGavin. 2006. Bacterial Genomes and Infectious Diseases. Bacterial Genomes and Infectious Diseases
191
212
.
M. Landgren, H. Odén, I. Kühn, A. Österlund & G. Kahlmeter. (2005) Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries. Journal of Antimicrobial Chemotherapy 55:6, pages 928-937.
Crossref
Crossref
P. H. H�ger. (2005) Kutane StaphylokokkeninfektionenCutaneous staphylococcal infections. Monatsschrift Kinderheilkunde 153:4, pages 330-341.
Crossref
Crossref
Jan Faergemann, Thomas Hedner & Peter Larsson. (2005) The in vitro Activity of Pentane-1,5-diol against Aerobic Bacteria. A New Antimicrobial Agent for Topical Usage?. Acta Dermato-Venereologica -1:1, pages 1-1.
Crossref
Crossref
E. Lindberg, I. Adlerberth & A.E. Wold. (2004) Antibiotic resistance in Staphylococcus aureus colonising the intestines of Swedish infants. Clinical Microbiology and Infection 10:10, pages 890-894.
Crossref
Crossref
Alexander J. O'Neill, Anders R. Larsen, Anne S. Henriksen & Ian Chopra. (2004)
A Fusidic Acid-Resistant Epidemic Strain of
Staphylococcus aureus
Carries the
fusB
Determinant, whereas
fusA
Mutations Are Prevalent in Other Resistant Isolates
. Antimicrobial Agents and Chemotherapy 48:9, pages 3594-3597.
Crossref
Crossref
Barry Monk. (2004) Avoiding antibiotic resistance in eczema. Practice Nursing 15:8, pages 384-387.
Crossref
Crossref
Anjum Singal & Gurvinder P. Thami. (2014) Topical Antibacterial Agents in Dermatology. The Journal of Dermatology 30:9, pages 644-648.
Crossref
Crossref
Y. Tveten, A. Jenkins, A.G. Allum & B.-E. Kristiansen. (2003) Heterogeneity of methicillin-resistant Staphylococcus aureus isolated in Norway. Clinical Microbiology and Infection 9:8, pages 886-892.
Crossref
Crossref
E. Anne Eady & Jonathan H. Cove. (2003) Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections. Current Opinion in Infectious Diseases 16:2, pages 103-124.
Crossref
Crossref